Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cell cycle progression beyond the G1/S phase transition requires the activation of a transcription complex containing
histone nuclear factor P
(
HiNF-P
) and nuclear protein mapped to
ataxia telangiectasia
(p220(NPAT)) in response to cyclin dependent kinase 2 (CDK2)/cyclin E signaling. We show here that the potent co-activating properties of
HiNF-P
/p220(NPAT) on the histone H4 gene promoter, which are evident in the majority of human cell types, are sporadically neutralized in distinct somatic cell lines. In cells where
HiNF-P
and p220(NPAT) do not activate the H4 gene promoter,
HiNF-P
instead represses transcription. Our data suggest that the cell type specific expression of the cyclin-dependent kinase inhibitory (CKI) protein p57(KIP2) inhibits the
HiNF-P
dependent activation of the histone H4 promoter. We propose that, analogous to E2F proteins and other cell cycle regulatory proteins,
HiNF-P
is a bifunctional transcriptional regulator that can activate or repress cell cycle controlled genes depending on the cellular context.
...
PMID:HiNF-P is a bifunctional regulator of cell cycle controlled histone H4 gene transcription. 1716 57
HiNF-P
and its cofactor p220(NPAT) are principal factors regulating histone gene expression at the G(1)-S phase cell cycle transition. Here, we have investigated whether
HiNF-P
controls other cell cycle- and cancer-related genes. We used cDNA microarrays to monitor responsiveness of gene expression to small interfering RNA-mediated depletion of
HiNF-P
. Candidate
HiNF-P
target genes were examined for the presence of
HiNF-P
recognition motifs, in vitro
HiNF-P
binding to DNA, and in vivo association by chromatin immunoprecipitations and functional reporter gene assays. Of 177 proliferation-related genes we tested, 20 are modulated in
HiNF-P
-depleted cells and contain putative
HiNF-P
binding motifs. We validated that at least three genes (i.e.,
ATM
, PRKDC, and CKS2) are
HiNF-P
dependent and provide data indicating that the DNA damage response is altered in
HiNF-P
-depleted cells. We conclude that, in addition to histone genes,
HiNF-P
also regulates expression of nonhistone targets that influence competency for cell cycle progression.
...
PMID:The HiNF-P/p220NPAT cell cycle signaling pathway controls nonhistone target genes. 1797 76